Corinne Armari‐Alla

<i>BRAF</i> Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

Sébastien Héritier, Jean‐François Emile, Mohamed‐Aziz Barkaoui et al. · Journal of Clinical Oncology · 2016 · 335 citations · Full text

Medicine, Oncology, Pathology +12

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

Alain Fischer, Johan Provot, Jean‐Philippe Jaïs et al. · Journal of Allergy and Clinical Immunology · 2017 · 317 citations

Life Sciences, Immunology, Internal Medicine +11

Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age

Charlotte Rigaud, Mohamed Barkaoui, Caroline Thomas et al. · British Journal of Haematology · 2016 · 129 citations

Medicine, Pathology, Pharmacology +8

Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort

Nathalie Aladjidi, Helder Fernandes, Thierry Leblanc et al. · Frontiers in Pediatrics · 2015 · 79 citations · Full text

Life Sciences, Immunology, Pediatrics +13

Rituximab therapy for childhood Evans syndrome

Brigitte Bader‐Meunier, Nathalie Aladjidi, Françoise Bellmann et al. · Haematologica · 2007 · 61 citations · Full text

Medicine, Immunology, Pediatrics +9